Zymeworks, Inc.
Posted on: October 19, 2022
By: Kim Berlowitz
With: Comments Off on Zymeworks, Inc.
MTS served as exclusive financial advisor to Zymeworks on its exclusive global licensing agreement of Zanidatamab with Jazz Pharmaceuticals